Literature DB >> 10438699

Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome.

N G Ranen1, R E Pasternak, B W Rovner.   

Abstract

The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome).

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10438699     DOI： 10.1097/00019442-199908000-00012

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN： 1064-7481            Impact factor:   4.105


  5 in total

1.  Cases: Charles Bonnet syndrome: visual loss and hallucinations.

Authors:  M L Jackson; Joseph Ferencz
Journal:  CMAJ       Date:  2009-08-04       Impact factor: 8.262

Review 2.  Charles Bonnet syndrome: two case reports and review of the literature.

Authors:  Alberto Lerario; Andrea Ciammola; Barbara Poletti; Floriano Girotti; Vincenzo Silani
Journal:  J Neurol       Date:  2013-02-05       Impact factor: 4.849

3.  Visual hallucinatory syndromes: past, present, and future.

Authors:  Dominic H Ffytche
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

4.  Atypical charles bonnet syndrome.

Authors:  Priti Arun; Rajan Jain; Vaibhav Tripathi
Journal:  Indian J Psychol Med       Date:  2013-10

5.  Charles Bonnet Syndrome: Case series.

Authors:  Sonia Maria Dozzi Brucki; Leonel Tadao Takada; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2009 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.